Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Spire Healthcare Group Plc
Appointment of Joint Corporate Broker
Business
Jul 16 2025
5 min read

Appointment of Joint Corporate Broker

16 July 2025

Spire Healthcare Group plc

('Spire Healthcare', 'the Group' or 'the Company')

 

Appointment of Joint Corporate Broker

 

Spire Healthcare Group plc (LSE: SPI), a leading independent healthcare group in the UK, is pleased to announce the appointment of Joh. Berenberg, Gossler & Co KG, London Branch ("Berenberg") as its Joint Corporate Broker alongside J.P. Morgan Securities plc (which conducts its UK investment banking business as J.P. Morgan Cazenove), the Company's current Corporate Broker, with immediate effect.

 

Berenberg

Toby Flaux / Ben Wright / Detlir Elezi                                                      +44 (0) 203 207 7800

 

[ENDS]

 

For further information please contact:

 

Spire Healthcare: investors@spirehealthcare.com

Amie Gramlick: Director of Investor Relations & Commercial Finance

 

Instinctif Partners: spire@instinctif.com

Julian Walker

Tim Pearson

 

Registered Office and Head Office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

 

Registered number 09084066

 

 

 

About Spire Healthcare

Spire Healthcare is a leading independent healthcare group in the United Kingdom, running 38 hospitals and over 50 clinics, medical centres and consulting rooms across England, Wales and Scotland. It operates a network of private GPs and provides occupational health services to over 800 corporate clients. Working in partnership with over 8,600 experienced consultants, Spire Healthcare delivered tailored, personalised care to over 1 million inpatients, outpatients and daycase patients, and occupational health programme clients, in 2023, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand.

 

Spire Healthcare's well-located and scalable hospitals have delivered successful and award-winning outcomes, positioning the group well with patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI') providers. 98% of Spire Healthcare's inspected locations are rated 'Good,' 'Outstanding' or the equivalent by health inspectors in England, Wales and Scotland.

 

Spire Healthcare is listed on the London Stock Exchange and is a member of the FTSE 250.